Skip to main content
. 2023 Oct 10;114(12):4654–4663. doi: 10.1111/cas.15965

FIGURE 3.

FIGURE 3

Efficacy of in vivo near‐infrared photoimmunotherapy (NIR‐PIT) using cetuximab‐IR700 against Hep3B and HuH‐7 tumors. (A) Treatment schedule. (B, C) Tumor volume curves in Hep3B (B) and HuH‐7 tumors (C) (n = 8–9; mean ± SEM; repeated‐measures two‐way ANOVA followed by Tukey's test. **p < 0.01; ***p < 0.001; ****p < 0.0001 versus control.)